[
    [
        {
            "time": "2018-01-03",
            "original_text": "东北证券【新股】1月3日泰林生物、百川转债、乐普转债和希望转债申购",
            "features": {
                "keywords": [
                    "乐普转债",
                    "百川转债",
                    "希望转债",
                    "泰林生物",
                    "申购"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "东北证券【新股】1月3日泰林生物、百川转债、乐普转债和希望转债申购",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-03",
            "original_text": "乐普转债(123040)申购价值分析：当前转债平价高于面值 公司基本面较优",
            "features": {
                "keywords": [
                    "乐普转债",
                    "申购",
                    "转债平价",
                    "基本面"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普转债(123040)申购价值分析：当前转债平价高于面值 公司基本面较优",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-03",
            "original_text": "【睿·理财】新债申购分析报告：乐普转债（123040.SZ）",
            "features": {
                "keywords": [
                    "乐普转债",
                    "新债",
                    "申购",
                    "分析报告"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【睿·理财】新债申购分析报告：乐普转债（123040.SZ）",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]